Literature DB >> 25030515

Neurofibromatosis type 1: a multidisciplinary approach to care.

Angela C Hirbe1, David H Gutmann2.   

Abstract

Neurofibromatosis type 1 is a relatively common inherited disorder. Patients have a high predisposition to develop both benign and malignant tumours. Although many manifestations of neurofibromatosis type 1 affect the nervous system, other organs and tissues can also be affected. Because of the varying features and clinical heterogeneity inherent to this disorder, patients can present to different medical and surgical specialists and, therefore, the association of clinical symptoms with neurofibromatosis type 1 might not be appreciated. Thus, for prompt diagnosis and to provide optimum care for patients with neurofibromatosis type 1, clinicians must be aware of the diverse clinical features of this disorder. We advocate a multidisciplinary approach to care, entailing a dedicated team of specialists throughout the lifetime of the patient. As our understanding of this disorder deepens through basic laboratory and clinical investigations, swift implementation of new effective treatments becomes feasible.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25030515     DOI: 10.1016/S1474-4422(14)70063-8

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  111 in total

1.  An Ulnar Neurofibroma: Management with Sural Graft Reconstruction.

Authors:  X Paredes-Carnero; J A Álvarez-Jorge
Journal:  J Hand Microsurg       Date:  2015-06-04

2.  Cerebellar Hypoplasia and Dysmorphia in Neurofibromatosis Type 1.

Authors:  Sandra P Toelle; Andrea Poretti; Peter Weber; Tatjana Seute; Jacoline E C Bromberg; Ianina Scheer; Eugen Boltshauser
Journal:  Cerebellum       Date:  2015-12       Impact factor: 3.847

Review 3.  Current status of MEK inhibitors in the treatment of plexiform neurofibromas.

Authors:  Andrea M Gross; Eva Dombi; Brigitte C Widemann
Journal:  Childs Nerv Syst       Date:  2020-06-30       Impact factor: 1.475

4.  Overlooked Hoffa Fracture in a Patient With Neurofibromatosis-1.

Authors:  Martin Missmann; Karl Peter Benedetto
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2017-11-23

5.  Malignant peripheral nerve sheath tumor of the vagus nerve: an uncommon cause of progressive dyspnea.

Authors:  Felipe Welter Langer; Daiane Dos Santos; Giordano Rafael Tronco Alves; Gustavo Suertegaray; Carlos Jesus Pereira Haygert
Journal:  Radiol Bras       Date:  2017 Nov-Dec

Review 6.  [Hereditary tumor syndromes in neuropathology].

Authors:  C Mawrin
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

7.  Near-infrared imaging: an in vivo, non-invasive diagnostic tool in neurofibromatosis type 1.

Authors:  Antonietta Moramarco; Sandra Giustini; Italo Nofroni; Fabiana Mallone; Emanuele Miraglia; Chiara Iacovino; Stefano Calvieri; Alessandro Lambiase
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-12-30       Impact factor: 3.117

Review 8.  Whole-body magnetic resonance imaging in children: technique and clinical applications.

Authors:  Eric P Eutsler; Geetika Khanna
Journal:  Pediatr Radiol       Date:  2016-05-26

9.  Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience.

Authors:  Vera Espírito Santo; João Passos; Hipólito Nzwalo; Inês Carvalho; Filipa Santos; Carmo Martins; Lucília Salgado; Conceição E Silva; Sofia Vinhais; Miguel Vilares; Duarte Salgado; Sofia Nunes
Journal:  J Neurooncol       Date:  2020-02-27       Impact factor: 4.130

Review 10.  HSF1: Guardian of Proteostasis in Cancer.

Authors:  Chengkai Dai; Stephen Byers Sampson
Journal:  Trends Cell Biol       Date:  2015-11-18       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.